Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 273 Records) |
| Query Trace: Ovarian Neoplasms and IMPACT[original query] |
|---|
| Impact of the time interval between primary or interval surgery and adjuvant chemotherapy in ovarian cancer patients. Frontiers in oncology 2023 9 13 1221096. Alberto Farolfi, Elisabetta Petracci, Giorgia Gurioli, Gianluca Tedaldi, Claudia Casanova, Valentina Arcangeli, Andrea Amadori, Marta Rosati, Marco Stefanetti, Salvatore Luca Burgio, Maria Concetta Cursano, Cristian Lolli, Valentina Zampiga, Ilaria Cangini, Giuseppe Schepisi, Ugo De Gior |
| Establishment and validation of an immune infiltration predictive model for ovarian cancer. BMC medical genomics 2023 9 16 (1): 227. Zhenxia Song, Jingwen Zhang, Yue Sun, Zhongmin Jiang, Xiaoning L |
| SHP2 is involved in the occurrence, development and prognosis of cancer. Oncology letters 2023 8 26 (3): 393. Shu Li, Jialing Qu, Xiaotong Wang, Qin Zou, Chunli |
| Clinical Impact of Polygenic Risk Score for Breast Cancer Risk Prediction in 382 Individuals with Hereditary Breast and Ovarian Cancer Syndrome. Cancers 2023 8 15 (15): . Sarah Stiller, Stephan Drukewitz, Kathleen Lehmann, Julia Hentschel, Vincent Strehl |
| Prognostic impact of molecular profiles and molecular signatures in clear cell ovarian cancer. Cancer genetics 2023 8 278-279 9-16. Tine Henrichsen Schnack, Douglas-V N P Oliveira, Anne Pernille Christiansen, Claus Høgdall, Estrid Høgda |
| Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. Gynecologic oncology 2023 12 180 35-43. Ryan M Kahn, Pier Selenica, Thomas Boerner, Kara Long Roche, Yonghong Xiao, Tiffany Y Sia, Anna Maio, Yelena Kemel, Margaret Sheehan, Erin Salo-Mullen, Kelsey E Breen, Qin Zhou, Alexia Iasonos, Rachel N Grisham, Roisin E O'Cearbhaill, Dennis S Chi, Michael F Berger, Ritika Kundra, Nikolaus Schultz, Lora H Ellenson, Zsofia K Stadler, Kenneth Offit, Diana Mandelker, Carol Aghajanian, Dmitriy Zamarin, Paul Sabbatini, Britta Weigelt, Ying L L |
| RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer. Cancer cell international 2023 11 23 (1): 290. Xuedong Wang, Kui Deng, Jing Tao, Juan Zou, Yiting Du, Li D |
| Efficacy of poly (ADP-ribose) polymerase inhibitors monotherapy and the impact to subsequent platinum-based chemotherapy in breast cancer susceptibility genes1/2-mutated ovarian cancer patients with secondary platinum-sensitive relapse. Journal of ovarian research 2023 10 16 (1): 209. Yana Ma, Jiale Liu, Ning Li, Hualei Bu, Yongwen Huang, Chengjuan Jin, Hao Wen, Shuai Feng, Hui Zhang, Xiaorong Yang, Beihua Kong, Lingying Wu, Kun So |
| Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report. Gynecologic oncology 2024 8 190 104-112. Erik Škof, Vida Stegel, Vita Šetraj?i? Dragoš, Ana Blatnik, Brigita Gregori?, Petra Škerl, Gašper Klan?ar, Anja Zagožen Klasinc, Alenka Bomba?, Mateja Krajc, Srdjan Novakov |
| In Silico Prediction of BRCA1 and BRCA2 Variants with Conflicting Clinical Interpretation in a Cohort of Breast Cancer Patients. Genes 2024 7 15 (7): . Stefania Stella, Silvia Rita Vitale, Michele Massimino, Federica Martorana, Irene Tornabene, Cristina Tomarchio, Melissa Drago, Giuliana Pavone, Cristina Gorgone, Chiara Barone, Sebastiano Bianca, Livia Manzel |
| Impacts of cytoplasmic p53 aggregates on the prognosis and the transcriptome in lung squamous cell carcinoma. Cancer science 2024 7 . Kazuchika Nishitsuji, Remi Mito, Midori Ikezaki, Hiromu Yano, Yukio Fujiwara, Eri Matsubara, Taro Nishikawa, Yoshito Ihara, Kenji Uchimura, Naoyuki Iwahashi, Takuro Sakagami, Makoto Suzuki, Yoshihiro Komoha |
| Restoration of ARID1A Protein in ARID1A-deficient Clear Cell Carcinoma of the Ovary Attenuates Reactivity to Cytotoxic T Lymphocytes. Cancer genomics & proteomics 2024 6 21 (4): 414-420. Risa Tsunematsu, Aiko Murai, Yuka Mizue, Terufumi Kubo, Tasuku Mariya, Rena Morita, Kenji Murata, Takayuki Kanaseki, Tomohide Tsukahara, Yoshihiko Hirohashi, Tsuyoshi Saito, Toshihiko Torig |
| Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC). Urologic oncology 2024 6 . Sara Custodio-Cabello, Vilma Pacheco-Barcia, Magda Palka-Kotlowska, Laura Fernández-Hernández, Julio Fernández Del Álamo, Eduardo Oliveros-Acebes, Luis Cabezón-Gutiérr |
| Functional genetic variants of GEN1 predict overall survival of Chinese epithelial ovarian cancer patients. Journal of translational medicine 2024 6 22 (1): 577. Haoran Li, Jiao Wu, Qing Xu, Yangyang Pang, Yanzi Gu, Mengyun Wang, Xi Che |
| Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2024 5 34 (1): 88-98. Carolina Maria Sassu, Claudia Marchetti, Giorgia Russo, Angelo Minucci, Serena Maria Boccia, Alberto Benato, Camilla Nero, Alessia Piermattei, Pier Paolo Mattogno, Diana Giannarelli, Gabriella Ferrandina, Alessandro Olivi, Anna Fagotti, Giovanni Scamb |
| Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status. Gynecologic oncology 2024 5 187 170-177. Claudia Marchetti, Beyhan Ataseven, Anna M Perrone, Chiara Cassani, Robert Fruscio, Carolina M Sassu, Adriana I Apostol, Philipp Harter, Pierandrea De Iaco, Cristina Angela Camnasio, Malak Moubarak, Diana Giannarelli, Giovanni Scambia, Anna Fagot |
| Blood Lead Level as Marker of Increased Risk of Ovarian Cancer in BRCA1 Carriers. Nutrients 2024 5 16 (9): . Adam Kilja?czyk, Milena Matuszczak, Wojciech Marciniak, Ró?a Derkacz, Klaudia Stempa, Piotr Baszuk, Marta Bry?kiewicz, Krzysztof Lubi?ski, Cezary Cybulski, Tadeusz D?bniak, Jacek Gronwald, Tomasz Huzarski, Marcin R Lener, Anna Jakubowska, Marek Szwiec, Ma?gorzata Stawicka-Nie?acna, Dariusz Godlewski, Artur Prusaczyk, Andrzej Jasiewicz, Tomasz Kluz, Joanna Tomiczek-Szwiec, Ewa Kilar-Kobierzycka, Monika Sio?ek, Rafa? Wi?niowski, Renata Posmyk, Joanna Jarkiewicz-Tretyn, Ping Sun, Rodney J Scott, Steven A Narod, Jan Lubi?s |
| Long-term oncologic outcomes of unselected triple-negative breast cancer patients according to BRCA1/2 mutations. NPJ precision oncology 2024 4 8 (1): 96. Woong Ki Park, Soo Yeon Chung, You Jin Jung, Changhee Ha, Jong-Won Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Byung Joo Chae, Jeong Eon Lee, Sung-Won Kim, Jai Min Ryu, |
| Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health. BMC genomics 2024 4 25 (1): 416. Stephanie Andaluz, Bojin Zhao, Siddharth Sinha, Philip Naderev Panuringan Lagniton, Diogo Alpuim Costa, Xiaofan Ding, Miguel Brito, San Ming Wa |
| Risk factors for ovarian cancer by BRCA status: a collaborative case-only analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2024 2 . Kate Gersekowski, Renhua Na, Kathryn Alsop, Rachel Delahunty, Ellen L Goode, Julie M Cunningham, Stacey J Winham, Paul D P Pharoah, Honglin Song, Penelope M We |
| Assessing the impact of contraceptive use on reproductive cancer risk among women of reproductive age-a systematic review. Frontiers in global women's health 2024 11 5 1487820. Shayesteh Jahanfar, Julie Mortazavi, Amy Lapidow, Cassandra Cu, Jude Al Abosy, Kathyrn Morris, Juan Camilo Becerra-Mateus, Meredith Steinfeldt, Olivia Maurer, Jiang Bohang, Paola Andrenacci, Marwa Badawy, Moazzam A |
| AR (CAG) Microsatellite and APEX1 c.444T>G (p.Asp148Glu) Polymorphisms as Independent Prognostic Biomarkers in Prostate Cancer: Insights from an Argentinian Cohort. Cancers 2024 11 16 (22): . Gaston Pascual, Agustina Sabater, Juan Bizzotto, Rocio Seniuk, Pablo Sanchis, Sabrina Ledesma-Bazan, Estefania Labanca, Carlos Scorticati, Osvaldo Mazza, Elba Vazquez, Ayelen Toro, Federico Prada, Geraldine Gueron, Javier Cotigno |
| Prospective study on the association between 36 human blood cell traits and pan-cancer outcomes: a mendelian randomization analysis. BMC cancer 2024 11 24 (1): 1442. Jinghao Liang, Xinyi Zhou, Yijian Lin, Hongming Yin, Yuanqing Liu, Zixian Xie, Hongmiao Lin, Tongtong Wu, Xinrong Zhang, Zhaofeng Tan, Ziqiu Cheng, Weiqiang Yin, Zhihua Guo, Wenzhe Ch |
| The impact of pathogenic BRCA1/2 tumor mutation status on high grade serous epithelial ovarian cancer survival outcome: A multicenter study from Indonesia. SAGE open medicine 2024 11 12 20503121241299849. Sutrisno Sutrisno, Dina Marlina, Kevin Dominique Tjandraprawira, Putri Nadhira Adinda Adriansy |
| Impact of PARP inhibitors on progression-free survival in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective analysis. World journal of surgical oncology 2024 10 22 (1): 276. Yumei Zhou, Junfen |
| Prevalence and outcomes of germline pathogenic variants of homologous recombination repair genes in ovarian cancer. Cancer science 2024 10 . Maiko Miwa, Masakazu Kitagawa, Yuka Asami, Mayumi Kobayashi-Kato, Takafumi Watanabe, Aiko Ogasawara, Kengo Hiranuma, Hisamori Kato, Motonobu Saito, Yohei Miyagi, Tomoyasu Kato, Hiroshi Yoshida, Yukihide Momozawa, Takashi Kohno, Kouya Shiraishi, Kosei Hasega |
| TGF-?-regulated different iron metabolism processes in the development and cisplatin resistance of ovarian cancer. Oncology research 2024 1 32 (2): 373-391. Jianfa Wu, Qianyi Liao, L I Zhang, Suqin Wu, Zhou L |
| Rare copy-number variants as modulators of common disease susceptibility. Genome medicine 2024 1 16 (1): 5. Chiara Auwerx, Maarja Jõeloo, Marie C Sadler, Nicolò Tesio, Sven Ojavee, Charlie J Clark, Reedik Mägi, , Alexandre Reymond, Zoltán Kutal |
| Optical Genome Mapping Reveals the Landscape of Structural Variations and Their Clinical Significance in HBOC-Related Breast Cancer. Frontiers in bioscience (Landmark edition) 2024 1 29 (1): 2. Yanan Cheng, Li Dong, Dechao Bu, Lei Han, Yi Zhao, Juntian Liu, Xiaojing Guo, Hanli Xu, Jinpu |
| Endothelial Dysfunction Markers in Ovarian Cancer: VTE Risk and Tumour Prognostic Outcomes. Life (Basel, Switzerland) 2025 1 14 (12): . Inês Guerra de Melo, Valéria Tavares, Joana Savva-Bordalo, Mariana Rei, Joana Liz-Pimenta, Deolinda Pereira, Rui Medeir |
- Page last reviewed:Feb 1, 2024
- Content source: